Triple-Negative Breast Cancer (TNBC) Recruiting Phase 2 Trials for Lisinopril (DB00722)

Also known as: Triple-negative Breast Cancer

IndicationStatusPhase
DBCOND0067309 (Triple-Negative Breast Cancer (TNBC))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs